Skip to main content

Peer Review reports

From: Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients

Original Submission
22 Nov 2023 Submitted Original manuscript
12 Dec 2023 Reviewed Reviewer Report
23 Dec 2023 Reviewed Reviewer Report
10 Jan 2024 Author responded Author comments - Zhanjun Guo
Resubmission - Version 2
10 Jan 2024 Submitted Manuscript version 2
20 Jan 2024 Author responded Author comments - Zhanjun Guo
Resubmission - Version 3
20 Jan 2024 Submitted Manuscript version 3
24 Jan 2024 Reviewed Reviewer Report
1 Feb 2024 Reviewed Reviewer Report
5 Feb 2024 Author responded Author comments - Zhanjun Guo
Resubmission - Version 4
5 Feb 2024 Submitted Manuscript version 4
7 Feb 2024 Author responded Author comments - Zhanjun Guo
Resubmission - Version 5
7 Feb 2024 Submitted Manuscript version 5
10 Feb 2024 Reviewed Reviewer Report
11 Feb 2024 Author responded Author comments - Zhanjun Guo
Resubmission - Version 6
11 Feb 2024 Submitted Manuscript version 6
13 Feb 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
13 Feb 2024 Editorially accepted
26 Feb 2024 Article published 10.1186/s12885-024-11999-z

You can find further information about peer review here.

Back to article page